New rarebit vision test captures macular deficits hidden to acuity tests.

Acta Ophthalmol

Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Published: August 2015

Purpose: Evaluation of a new personal-computer-based vision test aimed for rapid and accurate assessment of macular conditions such as age-related macular degeneration (AMD).

Methods: The new test depends on segmented digits defined by rarebits, that is, receptive field-size bright dots briefly presented against a dark background. Digit size was fixed at 40 × 50 min of arc. Digit positions were varied at random within a 4.6 × 3.5-degree test field. There were no fixation demands. The number of rarebits per digit segment could be varied between 3 (the minimum needed for veridical perception) and 128, in 11 preset steps. The test task was to find the smallest rarebit number required to recognize the test digits. Thirty-seven patients with various stages of AMD and 25 control subjects participated in the evaluation, which also included a standard acuity test.

Results: Analysis of receiver operating characteristics indicated significantly better discrimination by the rarebit test. Rarebit numbers >16 appeared to reliably indicate the presence of oedema.

Conclusion: The rarebit test appeared well suited for fine grading of vision in AMD. The simple set-up and the lack of fixation demands made for practicable examinations of short durations. The test is available for free on the Internet.

Download full-text PDF

Source
http://dx.doi.org/10.1111/aos.12659DOI Listing

Publication Analysis

Top Keywords

test
9
vision test
8
fixation demands
8
rarebit test
8
rarebit
5
rarebit vision
4
test captures
4
captures macular
4
macular deficits
4
deficits hidden
4

Similar Publications

Introduction: Although there are numerous options for epilepsy treatment, its effective control continues unsatisfactory. Thus, search for alternative therapeutic options to improve the efficacy/safety binomial of drugs becomes very attractive to investigate. In this context, intranasal administration of antiseizure drugs formulated on state-of-the-art nanosystems can be a promising strategy.

View Article and Find Full Text PDF

Accumulating evidence is suggesting more frequent tropical-to-temperate transitions than previously thought. This raises the possibility that biome transitions could be facilitated by precursor traits. A wealth of ecological, genetic and physiological evidence suggests overlap between drought and frost stress responses, but the origin of this overlap, i.

View Article and Find Full Text PDF

Background: This study aimed to provide a comprehensive review of adverse events (AEs) associated with factor Xa (FXa) inhibitors in pediatric patients.

Methods: We searched PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and the European Union Clinical Trials Register for English-language records from the establishment of the database up to October 17, 2023.

View Article and Find Full Text PDF

Introduction: Colorectal cancer (CRC) is the second most common cause of cancer-related deaths globally. The gut microbiota, along with adenomatous polyps (AP), has emerged as a plausible contributor to CRC progression. This study aimed to scrutinize the impact of the FadA antigen derived from Fusobacterium nucleatum on the expression levels of the ANXA2 ceRNA network and assess its relevance to CRC advancement.

View Article and Find Full Text PDF

Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults.

Drugs Aging

January 2025

Program for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, 420 East 70th St, New York, NY, LH-36510063, USA.

There are several pharmacologic agents that have been touted as guideline-directed medical therapy for heart failure with preserved ejection fraction (HFpEF). However, it is important to recognize that older adults with HFpEF also contend with an increased risk for adverse effects from medications due to age-related changes in pharmacokinetics and pharmacodynamics of medications, as well as the concurrence of geriatric conditions such as polypharmacy and frailty. With this review, we discuss the underlying evidence for the benefits of various treatments in HFpEF and incorporate key considerations for older adults, a subpopulation that may be at higher risk for adverse drug events.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!